Client News

Posted: April 26, 2015, 12:09 am
Posted: April 25, 2015, 12:08 am
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
Posted: April 25, 2015, 12:08 am
[AP] - A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: Tonix Pharma rose 26.5 percent to $7.40. Trillium Therapeutic rose 16.4 percent to $11.12. Ebix Inc. rose 14.3 percent to ...
Posted: April 25, 2015, 12:08 am
Posted: April 24, 2015, 6:30 pm
[CNW Group] - Bayer MaterialScience Names BioAmber As Its Supplier For New Product Line - Bio-succinic acid forms backbone of innovative new bio-based polyurethanes for textiles
Posted: April 24, 2015, 11:29 am
[PR Newswire] - "Sustainability is becoming a purchasing decision criterion for consumers and is high on the agenda for the textiles industry. IMPRANIL® eco improves the ecological footprint for manufacturers, OEMs and brand owners. For the renewable raw materials for IMPRANIL® eco, we are happy to have partnered with BioAmber, a technology leader that will provide a reliable supply of these precursors in sufficient scale," said Nicholas Smith, Global Head of Textile Coating at Bayer MaterialScience. BioAmber has been working for over five years on the use of bio-succinic acid in polyurethanes. Bio-succinic acid brings differentiated performance when formulated by leading companies such as Bayer MaterialScience, and can substitute adipic acid to bring unique properties in applications such as synthetic leather, wood and metal coatings, elastomers and foams. Current adipic acid use in polyurethanes is 25% of the 3 million ton global market, representing 750,000 tons of annual consumption.
Posted: April 24, 2015, 11:29 am
[at noodls] - AstraZeneca and MedImmune, the Company's global biologics research and development arm, today announced that they have entered into a collaboration to accelerate and broaden the development of Innate Pharma ...
Posted: April 24, 2015, 5:03 am
[at noodls] - Innate Pharma SA (Euronext Paris: FR0010331421 - IPH) today announced that it has signed a co-development and commercialization agreement with AstraZeneca, along with MedImmune, its global biologics research ...
Posted: April 24, 2015, 5:01 am
[at noodls] - Aurinia Pharmaceuticals to Host Lupus Nephritis Opinion Leader Meeting and Webcast on May 5 in New York Victoria, British Columbia - April 23, 2015 -- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH; TSX:AUP) ...
Posted: April 23, 2015, 9:36 pm
[Business Wire] - Aurinia Pharmaceuticals Inc. today announced it will host a Lupus Key Opinion Leader breakfast on Tuesday, May 5 from 8:00 to 9:30 EDT in New York.
Posted: April 23, 2015, 9:07 pm
[GlobeNewswire] - DUBLIN, Ireland, April 23, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ...
Posted: April 23, 2015, 8:06 pm
[GlobeNewswire] - DUBLIN, Ireland -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs, today announced ...
Posted: April 23, 2015, 8:05 pm
Posted: April 23, 2015, 5:58 pm
Posted: April 23, 2015, 1:14 pm
[CNW Group] - BioAmber Announces Webcast of Fiscal First Quarter 2015 Financial Results
Posted: April 22, 2015, 8:05 pm
[PR Newswire] - MINNEAPOLIS, MN, April 22, 2015 /PRNewswire/ - BioAmber Inc. (NYSE and EURONEXT Paris:BIOA) today announced that it will report financial results for the first quarter 2015 on Thursday, May 7, 2015 after the close of the market. Accordingly, you should not place undue reliance on these forward-looking statements.
Posted: April 22, 2015, 8:05 pm